Skip to main content
ABCL logo
ABCL
(NASDAQ)
AbCellera Biologics Inc.
$5.67-- (--)
Loading... - Market loading

AbCellera Biologics (ABCL) Stock Price & Financial Analysis

AbCellera Biologics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.60 - $5.87
52-Week High$8.44
52-Week Low$2.75
Open$5.69
Volume2.86M
Average Volume (3M)6.60M
Market Cap1.72B
Shares Outstanding303.07M
Price to Sales (P/S)21.70
Price to Book (P/B)1.83
EV/EBITDA-11.61
Revenue (TTM)79.21M
Net Income (TTM)-136.99M
Free Cash Flow (TTM)-189.23M
EPS (TTM)$-0.46
Profit Margin-172.95%
Operating Margin-242.42%
Return on Equity (ROE)-14.60%
Debt to Equity0.15
50-Day MA$5.95
200-Day MA$4.49
52-Week Change13.63%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About AbCellera Biologics

What is the current stock price for ABCL?

As of the latest trading session, ABCL stock trades at $5.67. The 52-week range is $2.75–$8.44, with a day range of $5.60–$5.87.

What is the P/E ratio for ABCL?

The P/E ratio (Price-to-Earnings) for ABCL is shown in the Key Statistics section. This valuation metric helps compare AbCellera Biologics Inc. to industry peers.

Does ABCL pay dividends?

AbCellera Biologics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ABCL?

Based on 7 analysts, the consensus for ABCL is Buy.

What is the market cap of ABCL?

AbCellera Biologics's market capitalization is $1.72B, classifying it as a small-cap company. AbCellera Biologics operates in the Healthcare sector within the Biotechnology industry.